Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) EPS (Basic): 2010-2018

Historic EPS (Basic) for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to -$1.15.

  • EyePoint Pharmaceuticals' EPS (Basic) fell 193.33% to -$0.44 in Q3 2018 from the same period last year, while for Sep 2018 it was -$1.34, marking a year-over-year decrease of 179.40%. This contributed to the annual value of -$1.15 for FY2018, which is 121.15% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its EPS (Basic) stood at -$1.15 for FY2018, which was down 121.15% from -$0.52 recorded in FY2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' EPS (Basic) peaked at $0.22 during FY2015, and registered a low of -$1.15 during FY2018.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.68 (2016), whereas its average is -$0.78.
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 144.90% in 2015, then plummeted by 409.09% in 2016.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' EPS (Basic) stood at -$0.49 in 2014, then surged by 144.90% to $0.22 in 2015, then crashed by 409.09% to -$0.68 in 2016, then rose by 23.53% to -$0.52 in 2017, then plummeted by 121.15% to -$1.15 in 2018.